Glen Eagle Advisors, LLC Novartis Ag Transaction History

Glen Eagle Advisors, LLC

$593 Billion
Q3 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 1,040 shares of NVS stock, worth $102,325. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,040

Previous 1,040 -0.0%

Holding current value

$102,325

Previous $111 Million 8.04%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $77,758 - $90,190	840 Added 420.0%	1,040 $111 Million
Q1 2024 Jul 03, 2024	BUY	$95.27 - $108.47 $99,080 - $112,808	1,040 New	1,040 $101 Million
Q4 2023 Aug 13, 2024	BUY	$92.27 - $101.54 $65,696 - $72,296	712 Added 256.12%	990 $100 Million
Q3 2023 Aug 13, 2024	SELL	$94.73 - $105.13 $94 - $105	-1 Reduced 0.36%	278 $28.4 Million
Q2 2023 Aug 13, 2024	BUY	$92.52 - $104.91 $92 - $104	1 Added 0.36%	279 $28.1 Million
Q1 2023 Aug 13, 2024	SELL	$80.03 - $92.81 $6,002 - $6,960	-75 Reduced 21.25%	278 $25.6 Million
Q4 2021 Aug 13, 2024	SELL	$79.7 - $88.13 $7,970 - $8,813	-100 Reduced 22.08%	353 $30.9 Million
Q2 2021 Aug 13, 2024	BUY	$85.24 - $94.15 $2,557 - $2,824	30 Added 7.09%	453 $41.4 Million
Q4 2020 Aug 13, 2024	SELL	$78.07 - $94.43 $48,169 - $58,263	-617 Reduced 59.33%	423 $40 Million
Q2 2020 Aug 13, 2024	BUY	$80.93 - $91.1 $5,665 - $6,377	70 Added 21.21%	400 $35 Million
Q4 2019 Aug 13, 2024	BUY	$84.35 - $95.37 $2,783 - $3,147	33 Added 11.11%	330 $31.3 Million
Q1 2019 Aug 13, 2024	SELL	$75.32 - $86.15 $55,962 - $64,009	-743 Reduced 71.44%	297 $28.6 Million
Q3 2018 Aug 13, 2024	BUY	$66.94 - $77.43 $1,472 - $1,703	22 Added 11.0%	222 $19.1 Million
Q2 2018 Aug 13, 2024	SELL	$64.91 - $73.36 $1.04 Million - $1.17 Million	-15,970 Reduced 98.76%	200 $15.1 Million
Q1 2018 Aug 14, 2024	SELL	$70.39 - $84.15 $59,127 - $70,686	-840 Reduced 80.77%	200 $16.2 Million
Q1 2018 Aug 13, 2024	BUY	$70.39 - $84.15 $1.12 Million - $1.34 Million	15,970 Added 7985.0%	16,170 $16.2 Million
Q3 2017 Aug 13, 2024	SELL	$74.14 - $77.27 $62,277 - $64,906	-840 Reduced 80.77%	200 $17.2 Million
Q4 2016 Aug 12, 2024	SELL	N/A	-640	400 $29.1 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account

Glen Eagle Advisors, LLC Novartis Ag Transaction History